<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 56-year-old woman initially noticed dizziness in October, 1988, and later <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:hpo ids='HP_0001288'>gait disturbance</z:hpo> developed, associated with <z:hpo ids='HP_0001336'>myoclonus</z:hpo> and periodic synchronous discharge in the electroencephalogram </plain></SENT>
<SENT sid="1" pm="."><plain>On the basis of these clinical findings we made a diagnosis of <z:e sem="disease" ids="C0022336" disease_type="Disease or Syndrome" abbrv="">Creutzfeldt-Jakob disease</z:e> (<z:e sem="disease" ids="C0022336" disease_type="Disease or Syndrome" abbrv="">CJD</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Using RIA for ubiquitin (signal <z:chebi fb="7" ids="16670">peptide</z:chebi> of the ATP dependent proteolytic system), we measured the cerebrospinal fluid (CSF) ubiquitin levels </plain></SENT>
<SENT sid="3" pm="."><plain>The CSF level of ubiquitin was markedly elevated in this case five months after the initial symptoms (230.0 ng/ml) compared with <z:mpath ids='MPATH_458'>normal</z:mpath> values (14.3 +/- 1.1 ng/ml) and values in patients with senile <z:hpo ids='HP_0000726'>dementia</z:hpo> of Alzheimer type (21.3 +/- 6.1 ng/ml) and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (16.6 +/- 6.4 ng/ml) </plain></SENT>
<SENT sid="4" pm="."><plain>With progression of brain <z:mpath ids='MPATH_127'>atrophy</z:mpath> in this case, CSF levels of ubiquitin rapidly decreased to near the <z:mpath ids='MPATH_458'>normal</z:mpath> values </plain></SENT>
<SENT sid="5" pm="."><plain>These findings suggest that CSF ubiquitin concentration reflects the activity of the disease process in <z:e sem="disease" ids="C0022336" disease_type="Disease or Syndrome" abbrv="">CJD</z:e>, and it may be useful in the diagnosis of <z:e sem="disease" ids="C0022336" disease_type="Disease or Syndrome" abbrv="">CJD</z:e> </plain></SENT>
</text></document>